BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 3928324)

  • 1. Pirenzepine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in peptic ulcer disease and other allied diseases.
    Carmine AA; Brogden RN
    Drugs; 1985 Aug; 30(2):85-126. PubMed ID: 3928324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.
    Clissold SP; Campoli-Richards DM
    Drugs; 1986 Jul; 32(1):15-47. PubMed ID: 3527658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pirenzepine in the treatment of peptic ulcer disease. Review and commentary.
    Bianchi Porro G; Petrillo M
    Scand J Gastroenterol Suppl; 1982; 72():229-36. PubMed ID: 6753117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and selectivity of pirenzepine. Review and commentary.
    Texter EC; Reilly PA
    Scand J Gastroenterol Suppl; 1982; 72():237-46. PubMed ID: 6753118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of gastric acid secretion by selective and nonselective anticholinergics.
    Feldman M
    Gastroenterology; 1984 Feb; 86(2):361-6. PubMed ID: 6360787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Famotidine. Pharmacodynamic and pharmacokinetic properties and a preliminary review of its therapeutic use in peptic ulcer disease and Zollinger-Ellison syndrome.
    Campoli-Richards DM; Clissold SP
    Drugs; 1986 Sep; 32(3):197-221. PubMed ID: 2875864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agents with tricyclic structures for treating peptic ulcer disease.
    Berardi RR; Caplan NB
    Clin Pharm; 1983; 2(5):425-31. PubMed ID: 6354568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A selective antimuscarinic agent: pirenzepine. Review of its pharmacologic and clinical properties].
    Del Tacca M; Danesi R; Blandizzi C; Bernardini MC
    Minerva Dietol Gastroenterol; 1989; 35(3):175-89. PubMed ID: 2574837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of cimetidine and pirenzepine on peptone-stimulated gastric acid secretion in man.
    Londong W; Londong V; Prechtl R; Weber T; von Werder K
    Scand J Gastroenterol Suppl; 1980; 66():103-14. PubMed ID: 6941373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pirenzepine: a selective anticholinergic for peptic ulcer.
    Drug Ther Bull; 1985 Apr; 23(8):29-31. PubMed ID: 3888582
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of pirenzepine on L--amino acids stimulated gastric acid secretion and serum gastrin levels in peptic ulcer disease in men.
    Bertoglio S; Anfossi A; Arnulfo G; Valentini P; Berti Riboli E
    Scand J Gastroenterol Suppl; 1982; 72():179-84. PubMed ID: 6957988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical treatment of peptic ulcers.
    Deveney CW; Deveney KE
    Surg Annu; 1985; 17():219-33. PubMed ID: 3883541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effectiveness of cimetidine, pirenzepine and synthetic secretin on stimulated gastric acid secretion].
    Londong W; Londong V; Prechtl R; Schwanner A
    Z Gastroenterol; 1980 Jun; 18(6):306-13. PubMed ID: 6893378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of pirenzepine and cimetidine, alone and in combination, on 24-hour gastric acidity in duodenal ulcer disease.
    Mahachai V; Reilly P; Thomson AB
    Clin Ther; 1984; 7(1):98-111. PubMed ID: 6394132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of pirenzepine and cimetidine inhibition of centrally-mediated gastric acid and pepsin secretion in the gastric-fistula cat.
    Browning JG; Heathcote BV
    Arch Int Pharmacodyn Ther; 1983 Jun; 263(2):288-96. PubMed ID: 6411019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pirenzepine--an anticholinergic agent with selective antimuscarinic properties].
    Dotevall G; Jaup BH; Stockbrügger RW
    Lakartidningen; 1982 Oct; 79(41):3671-3. PubMed ID: 6897434
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of ulcers with pirenzepin. Results from clinic and practice].
    Krempler F; Sandhofer F; Kalk A
    Wien Med Wochenschr; 1982 Sep; 132(18):427-32. PubMed ID: 6760563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Selective muscarinic receptor antagonists].
    Kishimoto S; Kajiyama G; Miyoshi A
    Nihon Rinsho; 1984 Jan; 42(1):114-9. PubMed ID: 6371305
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of pirenzepine and atropine on peptone meal-stimulated gastric secretion and plasma gastrin in healthy volunteers, patients with duodenal ulcer and vagotomized patients.
    Lazzaroni M; Sangaletti O; Del Soldato P; Bianchi Porro G
    Digestion; 1985; 32(4):267-72. PubMed ID: 3840755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of gastrocepin in middle-aged and elderly patients with peptic ulcer].
    Kapitanenko AM; Shastin IV; Karnaukhov IuN; Merkur'ev ND; Smirnov PA
    Klin Med (Mosk); 1986 Mar; 64(3):95-6. PubMed ID: 3520141
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.